Purchase Order W81K0018P0040

This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for $599 worth of ropivacaine hydrochloride injection USP, 0.2% 200 mg/100 mL in 100 mL single-dose flexible containers. The place of performance is Park Ridge, Illinois and the completion date is April 21, 2022. No set-aside designation was used for this firm fixed price contract, which was awarded on April 20, 2022 to supply this generic anesthetic medication. As the Defense Logistics Agency...

The Defense Logistics Agency Troop Support Medical awarded a $623 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ropivacaine 0.2% 40mg/20ml vials. The place of performance is Conshohocken, Pennsylvania. The order is for 20ml vials of the specified anesthetic and will be delivered between July 13-14, 2023. DLA Troop Support Medical supports the medical readiness of armed forces personnel through its procurement and distribution programs. No subcontractors or set aside...

This is a federal delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of 400 mg/200 ml vials of the anesthetic medication Ropivacaine 0.2%. The delivery order is valued at $3,650.13 and is a firm fixed-price contract with an ultimate completion date of April 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4564677395 ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a pharmaceutical product, with a ceiling value of $3,573.71. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ropivacaine 0.2% 200 mg/100 ml intravenous solution. The contract has a fixed price of $1,876.82 and a completion date of August 6, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...

This federal contract award, valued at $1,337.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4566740588 - ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...

<p>The Defense Logistics Agency awarded a $244,950 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ropivacaine 0.5% 150 mg/30 ml vials. The place of performance is Conshohocken, Pennsylvania. The delivery order runs from June 23, 2023 through June 26, 2023 to supply the anesthetic drug to support DLA procurement programs. As the prime contractor, Amerisourcebergen will deliver the Ropivacaine vials without involvement of major subcontractors under the contract.</p>

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of Ropivacaine 0.2% 200 mg/100 mL, a local anesthetic medication, with a ceiling value of $1,029.75 and an ultimate completion date of August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to...

The Defense Logistics Agency awarded a $6,486.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride, a long-acting amide local anesthetic. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between September 4-5, 2023. The order was placed under an existing DLA pharmaceuticals contract vehicle to supply anesthetics and other drug products in support of U.S....

The Defense Logistics Agency awarded a $1,427 delivery order to Amerisourcebergen Drug Corporation for 4561625382 Ropivacaine 0.5% 150 mg/30 ml vials. The firm fixed price order is for 30 ml vials of the listed anesthetic to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown customer by July 28, 2023. No additional details were provided regarding the original solicitation requirements, any applicable government-wide acquisition contracts, or subcontracting...